Tacedinaline
Tacedinaline (N-acetyldinaline) is an inhibitor of the histone deacetylase (HDAC) with IC50s of 0.9, 0.9, 1.2 μM for recombinant HDAC 1, 2 and 3 respectively.
Product Specifications
CAS Number
112522-64-2
Product Name Alternative
N-acetyldinaline; CI-994; Goe-5549
UNSPSC
12352005
Hazard Statement
H319
Target
Apoptosis; HDAC
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CI-994.html
Purity
99.32
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(NC1=C(N)C=CC=C1)C2=CC=C(NC(C)=O)C=C2
Molecular Formula
C15H15N3O2
Molecular Weight
269.30
Precautions
H319
References & Citations
[1]Moradei OM, et al. Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity. J Med Chem. 2007 Nov 15;50 (23) :5543-6.|[2]Loprevite M, etal. In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines. Oncol Res. 2005;15 (1) :39-48.|[3]LoRusso PM, et al. Preclinical antitumor activity of CI-994. Invest New Drugs. 1996;14 (4) :349-56.|[4]Graziano MJ, et al. Immunotoxicity of the anticancer drug CI-994 in rats: effects on lymphoid tissue. Arch Toxicol. 1999 Apr-May;73 (3) :168-74.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
HDAC1; HDAC2; HDAC3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7056795 Inquire
Recombinant Bufo marinus Rhodopsin (RHO), partial
Sign In for Pricing
View Details R0686h 1 Each
Human CTXII / C-telopeptide of Collagen alpha-1 (II) chain Recombinant Protein
Sign In for Pricing
View Details MAB43201AF594 0.1 mL
Rat Monoclonal LAMP-1/CD107a Antibody (747201) [Alexa Fluor 594]
Sign In for Pricing
View Details 